Company Press Releases Kathleen Otto 4/5/24 Kathleen Otto 4/5/24 RSM US LLP Named One of Fortune's 100 Best Companies to Work For® in 2024 Read More Kathleen Otto 4/5/24 Kathleen Otto 4/5/24 Johnson & Johnson's CARVYKTI® Receives FDA Approval as First BCMA-Targeted Therapy for Multiple Myeloma Read More Kathleen Otto 4/4/24 Kathleen Otto 4/4/24 Deloitte Announces $2 Billion Investment in IndustryAdvantage™ to Drive Industry Transformation Read More Kathleen Otto 4/3/24 Kathleen Otto 4/3/24 Alpha Cognition Announces FDA Milestone and Strategic Developments for ALPHA-1062 in Alzheimer's Disease Therapy Read More Kathleen Otto 4/2/24 Kathleen Otto 4/2/24 McKesson Launches Project Oasis to Advance Health Equity in Underserved Communities Read More Kathleen Otto 4/2/24 Kathleen Otto 4/2/24 McKesson CEO Brian Tyler Earns St. George National Award for Cancer Advocacy Read More Kathleen Otto 4/2/24 Kathleen Otto 4/2/24 JPS Health Network Receives 2024 Gallup Exceptional Workplace Award for Employee Engagement Read More Kathleen Otto 3/28/24 Kathleen Otto 3/28/24 Re:wild and Colossal Biosciences Join Forces to Revolutionize Conservation Efforts Read More Kathleen Otto 3/27/24 Kathleen Otto 3/27/24 Revolutionizing Lupus Care with Advanced Predictive Blood Testing Read More Kathleen Otto 3/27/24 Kathleen Otto 3/27/24 CBRE Group Named to Fortune's Most Innovative Companies List for Second Consecutive Year Read More Kathleen Otto 3/26/24 Kathleen Otto 3/26/24 Nanoscope Therapeutics Announces Promising Results for MCO-010 Gene Therapy in Phase 2b RESTORE Trial Read More Kathleen Otto 3/25/24 Kathleen Otto 3/25/24 FUJIFILM Diosynth Biotechnologies Expands Partnership with argenx for Efgartigimod Manufacturing Read More Kathleen Otto 3/22/24 Kathleen Otto 3/22/24 Advancing Sustainable Urban Agriculture Through Scientific Innovation: Perkins&Will's Research Initiative Read More Kathleen Otto 3/21/24 Kathleen Otto 3/21/24 EY US Releases Second Annual Health Equity Outlook Report Read More Kathleen Otto 3/21/24 Kathleen Otto 3/21/24 North Texas Innovation Alliance Launches Urban Resilience Fellowship Program with UTA and UTD Read More Kathleen Otto 3/19/24 Kathleen Otto 3/19/24 Island Pharmaceuticals Successfully Completes Fully Underwritten Rights Issue Read More Kathleen Otto 3/18/24 Kathleen Otto 3/18/24 Deloitte Unveils CyberSphere™: A Cutting-Edge Cybersecurity Platform for Enhanced Operational Efficiency Read More Kathleen Otto 3/18/24 Kathleen Otto 3/18/24 Johnson & Johnson MedTech and NVIDIA Partner for Edge-Based Surgical Data Analysis Advancements Read More Kathleen Otto 3/15/24 Kathleen Otto 3/15/24 Lantern Pharma Initiates Phase 1 Trial for LP-284: Pioneering AI-Driven Cancer Therapies Read More Kathleen Otto 3/14/24 Kathleen Otto 3/14/24 Polsinelli Launches Solare: A Robust Brand Protection Initiative Read More Newer Posts Older Posts
Kathleen Otto 4/5/24 Kathleen Otto 4/5/24 RSM US LLP Named One of Fortune's 100 Best Companies to Work For® in 2024 Read More
Kathleen Otto 4/5/24 Kathleen Otto 4/5/24 Johnson & Johnson's CARVYKTI® Receives FDA Approval as First BCMA-Targeted Therapy for Multiple Myeloma Read More
Kathleen Otto 4/4/24 Kathleen Otto 4/4/24 Deloitte Announces $2 Billion Investment in IndustryAdvantage™ to Drive Industry Transformation Read More
Kathleen Otto 4/3/24 Kathleen Otto 4/3/24 Alpha Cognition Announces FDA Milestone and Strategic Developments for ALPHA-1062 in Alzheimer's Disease Therapy Read More
Kathleen Otto 4/2/24 Kathleen Otto 4/2/24 McKesson Launches Project Oasis to Advance Health Equity in Underserved Communities Read More
Kathleen Otto 4/2/24 Kathleen Otto 4/2/24 McKesson CEO Brian Tyler Earns St. George National Award for Cancer Advocacy Read More
Kathleen Otto 4/2/24 Kathleen Otto 4/2/24 JPS Health Network Receives 2024 Gallup Exceptional Workplace Award for Employee Engagement Read More
Kathleen Otto 3/28/24 Kathleen Otto 3/28/24 Re:wild and Colossal Biosciences Join Forces to Revolutionize Conservation Efforts Read More
Kathleen Otto 3/27/24 Kathleen Otto 3/27/24 Revolutionizing Lupus Care with Advanced Predictive Blood Testing Read More
Kathleen Otto 3/27/24 Kathleen Otto 3/27/24 CBRE Group Named to Fortune's Most Innovative Companies List for Second Consecutive Year Read More
Kathleen Otto 3/26/24 Kathleen Otto 3/26/24 Nanoscope Therapeutics Announces Promising Results for MCO-010 Gene Therapy in Phase 2b RESTORE Trial Read More
Kathleen Otto 3/25/24 Kathleen Otto 3/25/24 FUJIFILM Diosynth Biotechnologies Expands Partnership with argenx for Efgartigimod Manufacturing Read More
Kathleen Otto 3/22/24 Kathleen Otto 3/22/24 Advancing Sustainable Urban Agriculture Through Scientific Innovation: Perkins&Will's Research Initiative Read More
Kathleen Otto 3/21/24 Kathleen Otto 3/21/24 EY US Releases Second Annual Health Equity Outlook Report Read More
Kathleen Otto 3/21/24 Kathleen Otto 3/21/24 North Texas Innovation Alliance Launches Urban Resilience Fellowship Program with UTA and UTD Read More
Kathleen Otto 3/19/24 Kathleen Otto 3/19/24 Island Pharmaceuticals Successfully Completes Fully Underwritten Rights Issue Read More
Kathleen Otto 3/18/24 Kathleen Otto 3/18/24 Deloitte Unveils CyberSphere™: A Cutting-Edge Cybersecurity Platform for Enhanced Operational Efficiency Read More
Kathleen Otto 3/18/24 Kathleen Otto 3/18/24 Johnson & Johnson MedTech and NVIDIA Partner for Edge-Based Surgical Data Analysis Advancements Read More
Kathleen Otto 3/15/24 Kathleen Otto 3/15/24 Lantern Pharma Initiates Phase 1 Trial for LP-284: Pioneering AI-Driven Cancer Therapies Read More
Kathleen Otto 3/14/24 Kathleen Otto 3/14/24 Polsinelli Launches Solare: A Robust Brand Protection Initiative Read More
